Candriam SCA’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-19,165
Closed -$444K 692
2024
Q4
$444K Hold
19,165
﹤0.01% 630
2024
Q3
$520K Hold
19,165
﹤0.01% 629
2024
Q2
$551K Buy
19,165
+4,767
+33% +$146K ﹤0.01% 624
2024
Q1
$420K Hold
14,398
﹤0.01% 665
2023
Q4
$468K Hold
14,398
﹤0.01% 661
2023
Q3
$461K Sell
14,398
-58,842
-80% -$2.27M ﹤0.01% 625
2023
Q2
$3.21M Sell
73,240
-6,485
-8% -$299K 0.02% 414
2023
Q1
$3.25M Sell
79,725
-12,266
-13% -$542K 0.02% 463
2022
Q4
$3.65M Hold
91,991
0.02% 446
2022
Q3
$4.25M Sell
91,991
-2,286
-2% -$112K 0.03% 418
2022
Q2
$4.07M Hold
94,277
0.03% 355
2022
Q1
$5.09M Sell
94,277
-75
-0.1% -$3.83K 0.03% 348
2021
Q4
$5.65M Buy
94,352
+5,856
+7% +$365K 0.04% 337
2021
Q3
$5.8M Buy
88,496
+22,127
+33% +$1.44M 0.04% 370
2021
Q2
$4.19M Buy
+66,369
New +$3.81M 0.03% 442

Other funds holding KIDS

Candriam SCA's KIDS Position: Q1 2025 in Review

Candriam SCA sold out of OrthoPediatrics (KIDS) in Q1 2025, closing a stake of 19,165 shares — an estimated $444K sold.

Candriam SCA first reported a position in KIDS in Q2 2021 and held it in 15 quarters. The position peaked at $5.8M in Q3 2021. 115 funds tracked by Wall St. Rank hold KIDS as of Q1 2025.

  • Candriam SCA reported no remaining OrthoPediatrics position as of Q1 2025 after selling out during the quarter.
  • Candriam SCA sold 19,165 OrthoPediatrics shares in Q1 2025, an estimated $444K.
  • Candriam SCA first reported a position in OrthoPediatrics in Q2 2021 and held it in 15 quarters.
  • Candriam SCA's OrthoPediatrics position peaked at $5.8M in Q3 2021.
  • 115 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2025.

Based on Candriam SCA's 13F filing for Q1 2025, filed 14 May 2025.